🇺🇸 FDA
Patent

US 7172876

Method of screening therapeutic agents for nerve degeneration associated diseases

granted A61PA61P25/00A61P25/14

Quick answer

US patent 7172876 (Method of screening therapeutic agents for nerve degeneration associated diseases) held by Takeda Pharmaceutical Company Limited expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/28